Coronavirus Update: Moderna’s Variant-Targeting Vaccine Moves Into Trial, J&J Looks Set For US Authorization
Plus: Sanofi/GSK Restart Vaccine Trials
• By Scrip Team
Moderna is investigating the variant-targeted vaccine as a low-dose booster and in a multivalent form combining it with the authorized version. (JOSEPH PREZIOSO/AFP via Getty Images)
Keep up with the top pharma business news of the week. On the go.
